About Spandan Khandelwal
Spandan's is a financial journalist and investment analyst focused on the stock market. With her ability to interpret financial data, she aims to help investors evaluate the fundamentals of a company before investing.
Spandan majored in accounting and finance in college and is currently pursuing the Cost and Management Accountant (CMA) program.
Recent Articles By Spandan Khandelwal
2 Metaverse Stocks That Reported Disappointing Earnings Results
Considering the metaverse’s immense growth prospects, tech giants are investing heavily in the space. However, not all companies working in the space or using the technology have performed well in the last reported quarter. Metaverse stocks Roblox Corporation (RBLX) and Unity Software (U) posted disappointing earnings in their latest quarterly results. So, let’s take a closer look at these names. Read on.
1 Biotech Stock to Buy and 1 to Sell
Increasing investments in R&D to develop new therapies, rising cases of chronic diseases, and an aging population should drive the biotech market’s growth. Therefore, we think it could be wise to invest in the shares of fundamentally sound biotech company Vertex Pharmaceuticals (VRTX). Conversely, we think the shares of Galmed Pharmaceuticals (GLMD) should be avoided now because of the company’s poor financial prospects. Let’s discuss.
Take Advantage of the Sell-Off and Buy These 4 Large-Cap Stocks Now
The stock market has been under immense pressure due primarily to surging inflation, the Fed's aggressive interest rate increase, and geopolitical tensions. However, we think now could be an opportune time to scoop up fundamentally sound large-cap stocks Trimble (TRMB), Wipro Limited (WIT0), STMicroelectronics (STM), and James Hardie Industries (JHX). Read on.
2 Consumer Cyclical Stocks to Avoid After Slashing Outlooks
Since the Fed’s aggressive interest rate hikes to fight inflation might tip the economy into recession, cyclical stocks could witness a significant downtrend. Therefore, we think it could be wise to avoid shares of cyclical companies Lear Corporation (LEA) and 1-800-FLOWERS (FLWS), which have cut their full-year guidance. Read on.
3 Stocks to Buy as the Metaverse Continues to Grow
The metaverse is the next step in technological innovation. It aims to deliver multidimensional virtual places using augmented and virtual realities. Since metaverse could drive the next big opportunity in the tech space, we think it could be wise to invest in fundamentally sound metaverse stocks Microsoft Corporation (MSFT), Cisco Systems, Inc. (CSCO), and Taiwan Semiconductor Manufacturing Company Limited (TSM). Let’s discuss.
3 Stocks Whose Price Target Were Recently Raised by Wall Street Analysts
The recent market correction caused by surging inflation, the Fed’s hawkish stance, and fears of an economic slowdown have taken a massive toll on investor sentiment. Nevertheless, amid the market downturn, Wall Street Analysts have raised the price targets for McKesson (MCK), GoDaddy (GDDY), and LyondellBasell Industries (LYB). So, let’s take a closer look at these names and learn why.
Outperform Rising Inflation with These 3 Dividend Stocks
Persistently high inflation and other economic uncertainties continue to spook investors. Amid this environment, we think investors should consider investing in companies that offer products and services that face inelastic demand and whose stock provides stable returns in the form of dividends. Therefore, it could be wise to bet on dividend stocks Anthem (ANTM), Enterprise Products (EPD), and Archer-Daniels-Midland (ADM) to beat the high inflation. Read on.
2 High-Quality Software Stocks That Look Cheap
Concerns over the Fed's aggressive monetary policy stance and the consequences of the Ukraine-Russia war have driven a massive tech sell-off lately. However, since the robust demand for software solutions with continuing digitization is expected to drive the industry’s growth, we think high-quality software stocks Progress Software (PRGS) and Amdocs Limited (DOX), which are currently trading at discounts to their peers, could rebound soon. Read on.
3 Stocks to Buy After Handily Beating Earnings Estimates
Given current market volatility due to concerns over the Fed's tighter monetary policy to tame surging inflation and fears of an economic slowdown, we think investors should consider buying stocks with sound fundamentals and solid growth attributes. Nutrien (NTR), Merck & Co (MRK), and Bunge (BG) recently reported promising quarterly results, beating consensus earnings estimates. So, these stocks could be great additions to one’s portfolio now. Read on.